Signs and Symptoms of Tuberous Sclerosis
What Are the Signs and Symptoms of Tuberous Sclerosis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 9, 2020 Category: General Medicine Source Type: news
NeuroPace Removes Barrier for Epilepsy Treatment Through FDA Nod
NeuroPace is spicing up the neuromodulation market a bit with a new nod from FDA for MRI labeling for the RNS system. The Mountain View, CA-based company’s RNS System treats patients living with seizures that do not respond to medication and first landed a PMA in November of 2013.
In a release, the company said individuals with focal onset seizures that also have brain anomalies that require monitoring, such as tuberous sclerosis, brain tumors or multiple sclerosis, as well as those with non-brain MRI requirements, can now be offered the RNS System as a treatment option.
The company added this will also a...
Source: MDDI - March 9, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Regulatory and Compliance Source Type: news
Getting Quality Autism Therapy From Thousands of Miles Away
TUESDAY, Feb. 25, 2020 -- By the time he was 7 months old, John Michael Crawford had been diagnosed with a rare genetic disorder called tuberous sclerosis, associated with a high risk of developmental delays, including autism.
Early intervention... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 25, 2020 Category: General Medicine Source Type: news
Purified CBD May Help Treat Drug-Resistant Epilepsy
TUESDAY, Dec. 10, 2019 -- Among patients with tuberous sclerosis complex (TSC), the reduction in the frequency of TSC-associated seizures was greater in those receiving a purified version of cannabidiol (CBD) than in those receiving placebo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 10, 2019 Category: Pharmaceuticals Source Type: news
Cannabis Drug Promising for Seizures Linked to Tuberous Sclerosis Cannabis Drug Promising for Seizures Linked to Tuberous Sclerosis
A cannabidiol-derived drug approved for the treatment of Dravet and Lennox-Gastaut syndromes also reduces seizures in patients with tuberous sclerosis complex.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - December 9, 2019 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news
CBD Medicine May Help Ease Another Form of Seizure
SATURDAY, Dec. 7, 2019 -- Prescription-grade CBD may help control hard-to-treat seizures caused by a rare genetic disorder, a preliminary study suggests.
The study involved 224 patients with tuberous sclerosis complex (TSC) -- a genetic condition... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2019 Category: General Medicine Source Type: news
UM Medicine launches treatment centers for adult neurodevelopmental issues
(University of Maryland School of Medicine) The University of Maryland School of Medicine (UMSOM), University of Maryland Medical Center (UMMC), and the Tuberous Sclerosis Alliance (TS Alliance) have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2019 Category: International Medicine & Public Health Source Type: news
UCLA scientists honored with Presidential Early Career Awards
Two UCLA scientists are recipients of the 2019 Presidential Early Career Award for Scientists and Engineers for their “exceptional promise for leadership in science and technology.”The PECASE is the federal government ’s highest honor recognizing scientists for their contributions to science, technology, engineering and mathematics education. It also recognizes community service as demonstrated by scientific leadership, public education and community outreach.The White House Office of Science and Technology Policy coordinates the awards with participating departments and agencies. The awards ceremony is July 25 in...
Source: UCLA Newsroom: Health Sciences - July 12, 2019 Category: Universities & Medical Training Source Type: news
What Causes Macrocephaly?
Discussion
“Macrocephaly is defined as [an occipitofrontal circumference or head circumference, OFC ] of > 2 standard deviations above the mean or above the 97th percentage for a given age, and gender, or when serial measurement shows progressive enlargement, crossing of one or more major percentiles, or when there is an increase in OFC > 2 cm/month in the first 6 months of life.” Megalencephaly is enlargement of the brain parenchyma. The OFC should be measured using a non-elastic tape which surrounds the head along the line of the glabella and posterior occipital protrusion.
There are ethnic differences...
Source: PediatricEducation.org - May 20, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
GW Pharma's epilepsy drug meets main goal in late-stage trial
GW Pharmaceuticals Plc said on Monday its drug Epidiolex was successful in treating seizures in patients with a rare form of childhood epilepsy called tuberous sclerosis complex during a late-stage trial. (Source: Reuters: Health)
Source: Reuters: Health - May 6, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Terminally Ill Boy Exposed to Measles
The 7-year-old has a condition called tuberous sclerosis. His mother said doctors told her that her son was exposed to measles by an unvaccinated child who had caught the disease while overseas. (Source: WebMD Health)
Source: WebMD Health - April 4, 2019 Category: Consumer Health News Source Type: news
Two independent mechanisms are involved in tuberous sclerosis
(Baylor College of Medicine) The development of the rare condition called tuberous sclerosis involves mTORC1-dependent and -independent mechanisms. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 7, 2019 Category: Biology Source Type: news
MGH receives $50M gift from founder of Princeton Properties
Massachusetts General Hospital has received its third largest gift in its history, a $50 million donation from James S. and Carol J. Herscot.
The funding will go toward a variety of capital projects and to the Center for Children and Adults with Tuberous Sclerosis Complex, which currently bears the Herscot's name. The hospital will also rename an outpatient facility that houses the Herscot Center after the family.
“Jim and Carol hav e been among the hospital’s strongest supporters and champions… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 6, 2019 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news
MGH receives $50M gift from founder of Princeton Properties
Massachusetts General Hospital has received its third largest gift in its history, a $50 million donation from James S. and Carol J. Herscot.
The funding will go toward a variety of capital projects and to the Center for Children and Adults with Tuberous Sclerosis Complex, which currently bears the Herscot's name. The hospital will also rename an outpatient facility that houses the Herscot Center after the family.
“Jim and Carol hav e been among the hospital’s strongest supporters and champions… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2019 Category: Biotechnology Authors: Jessica Bartlett Source Type: news
Earlier treatment could help reverse autistic-like behavior in tuberous sclerosis
(Boston Children's Hospital) New research in a mouse model suggests that the drug rapamycin can reverse autism-like social deficits -- but only if given early. The study is the first to shed light on the crucial timing of therapy to improve social impairments in a condition associated with autism spectrum disorder. Its findings could help inform future clinical trials in children with tuberous sclerosis complex. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 9, 2018 Category: International Medicine & Public Health Source Type: news
